Hans H. Lindén

When poor solubility becomes an issue: From early stage to proof of concept

Sven Stegemann, F. Leveiller, D. Franchi et al. · European Journal of Pharmaceutical Sciences · 2007 · 504 citations

Pharmacy, Chemistry, Materials Science +14

Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT)

Buket Aksu, Thomas De Beer, Staffan Folestad et al. · European Journal of Pharmaceutical Sciences · 2012 · 65 citations

Pharmacy, Pharmaceutical Policy, Quality Management +9

Towards a European Strategy for Medicines Research (2014–2020): The EUFEPS Position Paper on Horizon 2020

Rogério Gaspar, Buket Aksu, A. Cuiné et al. · European Journal of Pharmaceutical Sciences · 2012 · 38 citations

Pharmacy, Pharmaceutical Policy, Translational Medicine +6

European initiative towards quality standards in education and training for discovery, development and use of medicines

H Klech, Cath Brooksbank, Patrice Verpillat et al. · European Journal of Pharmaceutical Sciences · 2011 · 20 citations

Public Affairs, Health Education, Medical Education +12

Strategic framework for education and training in Quality by Design (QbD) and process analytical technology (PAT)

Marcel de Matas, Thomas De Beer, Staffan Folestad et al. · European Journal of Pharmaceutical Sciences · 2016 · 20 citations

Management, Educational Technology, Quality Management +14